Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Advanced Cancer × Trastuzumab × Clear all

Phase

Status

Sponsor Class

OTHER 1 NETWORK 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 306 Stomach Neoplasms 27 Neoplasm Metastasis 25 HER2-positive Breast Cancer 19 Neoplasms 15 Breast Neoplasms, Male 15 Esophageal Neoplasms 10 Colorectal Neoplasms 10 Brain Neoplasms 10 Inflammatory Breast Neoplasms 8 Triple Negative Breast Neoplasms 7 Adenocarcinoma 6 Prostatic Neoplasms 5 Ovarian Neoplasms 5 Cardiotoxicity 5 Carcinoma, Non-Small-Cell Lung 5 Biliary Tract Neoplasms 5 Salivary Gland Neoplasms 4 Pathologic Complete Response 4 Pancreatic Neoplasms 4 Meningeal Neoplasms 4 Lung Neoplasms 4 Colonic Neoplasms 4 Carcinoma, Ductal, Breast 4 Recurrence 3 Rectal Neoplasms 3 Meningeal Carcinomatosis 3 Gallbladder Neoplasms 3 Breast Diseases 3 Anatomic Stage I Breast Cancer AJCC v8 3

Interventions

Surveys and Questionnaires 7 Bevacizumab 5 temsirolimus 4 Standard of Care 4 Sirolimus 4 Interviews as Topic 4 Vorinostat 2 Paclitaxel 2 Olanzapine 2 Magnetic Resonance Spectroscopy 2 Everolimus 2 Erlotinib Hydrochloride 2 Cetuximab 2 zaleplon 1 vistusertib 1 tilsotolimod 1 pazopanib 1 olaparib 1 olanzapine-fluoxetine combination 1 liposomal doxorubicin 1 capivasertib 1 apatinib 1 Videotape Recording 1 Vemurafenib 1 Valproic Acid 1 Trastuzumab 1 Topotecan 1 Temozolomide 1 Sunitinib 1 Sorafenib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00543504 2020-06-30

Bevacizumab in Multiple Phase I Combinations

M.D. Anderson Cancer Center

Phase 1 Completed

Advanced Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡